I guess a lot more BS press releases to come. Good for a laugh at least.
Dr. Lawrence Salvo will have to do his due diligence on Generex. What do you think he will find? They are using him so that they can jack up the stock price. Just because you mention $15 million price tag does not mean that people won't see if for what this is. BS.
They are so full of Sjx!@. Talk about wanting to fool the market place to keep their salaries and fees going. Who needs to sell shares to pay their phone bill this month.
Why bother filing? All they would have to do is not file the Qs and trading would stop. Then no more salaries or money for rent or phones etc..
So far they have announced an animal experiment with Oral-lyn, a White Paper written by a Board member, a cannabis story and the commencement of R&D without a licensing deal. None of these have taken the stock over a penny and 1/2. The same stories are not going to make the stock go up after the roll back either. JMHO.
This is a new one from the Puppet Show. Who starts R&D before finalizing a licensing agreement. Who? Normally a company does trials on its own or licenses it out to a partner who conducts studies. Just goes to show that there is nothing left to protect at this company. If there was any merit to it why didn't management make a quote on today's Press Release?
That is all baby. Keep selling shares and sucker in some investors for their salaries.
They gotta pay the rent!!
So they started with LOIs a little while ago. Now they will start with co-development plans. No business ever.
Gotta pay for the rent. Right. They will never pay for co-development of anything. Just ask Dr. Eric Von Hofe. Better yet just look at the Financial Statements. Proof.
The point I am making is that banking firms have investment requirements. Even if they are not dealing with blue chip guys they still have some basic requirements. They keep on losing money and still investing. Just odd. Unless they are doing it just for fees and then who cares about losing money for the investor? Who knows. JMHO.